Carisma Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.00
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-09-30
|
-0.57
|
-0.53
|
0.04
|
7.02%
|
|
2023-06-30
|
-0.60
|
-0.49
|
0.11
|
18.33%
|
|
2023-03-31
|
-0.89
|
-1.93
|
-1.04
|
-116.85%
|
|
2022-12-31
|
-2.20
|
-0.80
|
1.40
|
63.64%
|
|
2022-09-30
|
-3.10
|
2.00
|
5.10
|
164.52%
|
|
2022-06-30
|
-2.60
|
-3.20
|
-0.60
|
-23.08%
|
|
2022-03-31
|
-2.00
|
-0.08
|
1.92
|
95.96%
|
|
2021-12-31
|
-1.47
|
0.80
|
2.27
|
154.42%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2023-12-31
|
-2.95
|
|
2022-12-31
|
-2.08
|
|
2021-12-31
|
-2.00
|
|
2020-12-31
|
-4.60
|
|
2019-12-31
|
-24.00
|
|
2018-12-31
|
-13.92
|
|
2016-12-31
|
-13.49
|
|
2015-12-31
|
-35.00
|
|
2014-12-31
|
-49.20
|
|
2013-12-31
|
-293.20
|